Bausch Health Companies Inc BHC-CA:Toronto Stock Exchange
*Data is delayed | Exchange | CAD
Last | 05/10/24 EDT
9.42
-0.09 (-0.95%)
-0.09 (-0.95%)Volume
356,712
52 week range
7.56 - 15.43
- Open9.51
- Day High9.63
- Day Low9.32
- Prev Close9.51
- 52 Week High15.43
- 52 Week High Date04/03/24
- 52 Week Low7.56
- 52 Week Low Date05/12/23
Key Stats
- Market Cap2,816.19M
- Shares Out360.99M
- 10 Day Average Volume504,988.4
- Dividend-
- Dividend Yield-
- Beta0.44
- YTD % Change-11.38
KEY STATS
- Open9.51
- Day High9.63
- Day Low9.32
- Prev Close9.51
- 52 Week High15.43
- 52 Week High Date04/03/24
- 52 Week Low7.56
- 52 Week Low Date05/12/23
- Market Cap2,816.19M
- Shares Out360.99M
- 10 Day Average Volume504,988.4
- Dividend-
- Dividend Yield-
- Beta0.44
- YTD % Change-11.38
RATIOS/PROFITABILITY
- EPS (TTM)-1.68
- P/E (TTM)-5.59
- Fwd P/E (NTM)-
- EBITDA (TTM)-
- ROE (TTM)-
- Revenue (TTM)-
- Gross Margin (TTM)-
- Net Margin (TTM)-
- Debt To Equity (MRQ)-
EVENTS
- Earnings Date-
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Latest On Bausch Health Companies Inc
Content From Our Affiliates
Related Video
Profile
MOREBausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Controller
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada